Amneal Pharmaceuticals Competitors and Similar CompaniesClear all
Amneal Pharmaceuticals's competitors and similar companies include Shionogi, Sagent Pharmaceuticals and Spirovant Sciences.
 Amneal Pharmaceuticals Amneal Pharmaceuticals is a company engaged in the development, manufacturing, and distribution of generic and specialty pharmaceutical products. |  Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. |  Sagent Pharmaceuticals Sagent Pharmaceuticals is focused on developing, manufacturing, sourcing and marketing pharmaceutical products. |  Spirovant Sciences Spirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases. | |
Founding Date | Founding Date 2002 | Founding Date 1878 | Founding Date 2006 | Founding Date 2016 |
Type | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations Bridgewater Township, US HQ Gröbenzell, DE Ahmedabad, IN Ahmedabad, IN Ahmedabad, IN Dahej, IN Mahabubnagar, IN see more | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more | Locations Schaumburg, US HQ | Locations Philadelphia, US HQ |
Employees | Employees 8,1005% increase | Employees 4,955 | Employees 2261% increase | Employees 234% decrease |
Valuation ($) | Valuation ($) 2.6 b | Valuation ($) 12.3 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $3b (FY, 2025) | Revenue (est.) ¥499.7b (FY, 2026) | Revenue (est.) $318.3m (FY, 2015) | Revenue (est.) N/A |
Cost of goods | Cost of goods $1.9b (FY, 2025) | Cost of goods ¥62.1b (FY, 2026) | Cost of goods $230.6m (FY, 2015) | Cost of goods N/A |
Gross profit | Gross profit $1.1b (FY, 2025) | Gross profit ¥484.8b (FY, 2026) | Gross profit $87.7m (FY, 2015) | Gross profit N/A |
Net income | Net income $127.9m (FY, 2025) | Net income ¥205.9b (FY, 2026) | Net income ($21.9m) (FY, 2015) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 4.7m | Total funding raised $ 70m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Shionogi
HQ
Osaka, JP
Employees
4,955
Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases.
View companySagent Pharmaceuticals
HQ
Schaumburg, US
Sagent Pharmaceuticals is focused on developing, manufacturing, sourcing and marketing pharmaceutical products.
View companySpirovant Sciences
HQ
Philadelphia, US
Employees
23↓ 4% decrease
Spirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases.
View company